Dr. Emil Lou, MD, PhD

Dr. Lou practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Lou's NPI, 1902062433, was assigned on August 4, 2008. Dr. Lou holds New York license 243630.

Dr. Lou's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Lou's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Lou is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Lou to 2 more hospitals, 2 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lou practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Lou's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lou is licensed in New York.

CMS data shows 31 Medicare services from Dr. Lou across 2 procedure codes in 2024, all of them office visits, for 58 Medicare patients. Medicare paid $3,482 for them. Every service was in an office.

CMS counts 58 Medicare patients who saw Dr. Lou in 2024. The largest group is 65 to 74, with 29 patients. 62% of them have high blood pressure, and 59% have cancer. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lou's median patient age at 64, with 42% women.

In 2024, Dr. Lou wrote 78 Medicare Part D claims for 23 patients. 77% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $246 in total drug cost. In 2023, CMS named 50 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lou for performance year 2024, reported as part of a group. Dr. Lou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lou as offering telehealth.

Dmand AI links 86 papers to Dr. Lou, published from 2018 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Biomarkers, Tumor, Colorectal Neoplasms and Pancreatic Neoplasms. Dr. Lou has published most often in Clin Cancer Res. Dr. Lou's most frequent co-authors are Wolfgang Michael Korn, MD, Heinz-Josef Lenz, MD and Moh'D M Th Khushman, MD.

CMS Open Payments shows 39 general payments to Dr. Lou from 5 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 35% of the total. Novocure Inc. paid the most, $13,237.